1.06 - Urological Cancer Flashcards
Risk factors for prostate cancer.
- family history
- African
- increased age
- chronic inflammation
- obesity
- smoking
- BRCA mutation
What is the most common type of prostate cancer?
Adenocarcinoma
Primary prevention of prostate cancer.
- smoking cessation
NB: no dietary supplements or medication are known to be effective in prevention.
Secondary prevention of prostate cancer.
- androgen deprivation therapy
- prostatectomy
Tumour marker associated with prostate cancer.
PSA - sensitive but not specific.
Differential diagnoses for prostate cancer.
- prostatitis
- BPH
- prostatic trauma (ie. DRE, catheterisation)
- long ride (e.g. airplane, cycling)
Presentation of prostate cancer.
- asymptomatic
- voiding symptoms
- haematuria
- hydronephrosis
- bone pain (?mets)
What scoring system is used to classify prostate cancer?
Gleason score
Laboratory tests for prostate cancer.
- PSA
- prostate cancer gene 3 (PCA3)
Imaging techniques used in prostate cancer.
Multiparametric MRI GOLD STANDARD
Ultrasound guided biopsy, and CT for staging, may be used.
What is the issue with prostate cancer screening?
Associated with potential harms of psychological and physical stress of over-treatment of an indolent cancer.
Treatment options of prostate cancer.
- watchful waiting
- active surveillance
- prostatectomy
- hormone therapy
- chemotherapy
- radiotherapy
- bisphosphonates
Role of watchful waiting in prostate cancer.
Avoids the use of surgery or radiation, often suitable in older men or those with significant comorbidities.
It is aimed at people with localised prostate cancer who are either not suitable for, or do not wish to receive, curative treatment.
Role of active surveillance in prostate cancer.
A curative strategy aimed at people with localised prostate cancer, keeping them within a ‘window of curability’.
Active surveillance may avoid or delay the need for radiotherapy or surgery.
Difference between active surveillance and watchful waiting.
Active surveillance includes repeating the prostate biopsy and PSA levels at intervals, to allow prognostic risk category to be reassessed.
Treatment is only offered when risk increases, but with curative intent, in active surveillance.
Types of radical treatments in prostate cancer.
- radical prostatectomy
- external beam radiotherapy
- brachytherapy
Role of hormonal treatments in prostate cancer.
Control of cancer by removing or blocking the effects of hormones that stimulate the growth of prostate cancer cells.
Androgen deprivation (ie. orchidectomy, LHRH agonists) and androgen blockades can be used.
When is chemotherapy indicated in prostate cancer?
Hormone-relapsed metastatic disease.
Role of bisphosphonates in prostate cancer.
Offered to people having androgen deprivation therapy and have osteoporosis.
What are the side effects of hormonal treatments in people with prostate cancer?
- hot flushes
- fatigue
- osteoporosis
- gynaecomastia
Side effects of radical prostatectomy.
- stress urinary incontinence
- erectile dysfunction
- infertility / aspermia
Pelvic floor muscle exercises and medical therapies.
Side effects of radiotherapy in prostate cancer.
- urinary incontinence
- bowel incontinence
- erectile dysfunction
- urethral strictures
- infertility
- haemorrhagic cystitis
- bladder irritation
- rectal irritation
Differential diagnoses for prostate mass detectable by DRE.
- prostate cancer
- normal asymmetry
- BPH
- prostatitis
- cyst
- prior TURP / biopsy scar